Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
Go back to Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.85 +0.44 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.41 | 52 Week High | $3.48 | |||
| Open | $58.56 | 52 Week Low | $0.80 | |||
| Day High | $58.86 | P/E | N/A | |||
| Day Low | $57.82 | EPS | $-1.54 | |||
| Volume | 1,531,904 | |||||
